<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Max Planck Gesellschaft zur Foerderung der Wissenschaften eV — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/max-planck-gesellschaft-zur-foerderung-der-wissenschaften-ev</link>
    <description>Plain-English explanations of patents assigned to Max Planck Gesellschaft zur Foerderung der Wissenschaften eV, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jun 2026 06:05:00 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/max-planck-gesellschaft-zur-foerderung-der-wissenschaften-ev/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Using Antibodies to Block HER3 Proteins in Cancer Cells</title>
      <link>https://patentbrief.org/patent/us/9011851/perjeta-pertuzumab</link>
      <description>A patent describing specific antibodies that bind to and block the HER3 protein, which is often used by cancer cells to grow and survive.</description>
      <pubDate>Tue, 21 Apr 2015 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/9011851/perjeta-pertuzumab</guid>
    </item>
  </channel>
</rss>
